Zorina, Yana http://orcid.org/0000-0002-0200-2742
Stricker, Jason
Caggiano, Anthony O.
Button, Donald C.
Article History
Received: 25 January 2018
Accepted: 1 June 2018
First Online: 20 June 2018
Competing Interests
: rHIgM22 is a proprietary molecule of Acorda Therapeutics, Inc. A.O.C., Y.Z., D.C.B. and J.S. are stockholders of AcordaTherapeutics. Inc. None of the authors declare non-financial competing interests.